DRE and Prostate Cancer

Friday 27th March 2020

A digital rectal examination (DRE) is a useful screening tool, which can be used in conjunction with a PSA test, to help determine if a patient should be referred on a prostate cancer pathway. Prostate cancers may not necessarily secrete PSA; and so a PSA alone may be falsely reassuring. Thus, a DRE can form an important part of the prostate cancer investigation process.

The examination:

All practitioners should be able to perform a DRE, as the prostate is positioned close to the anal vert, therefore the length of fingers do not restrict the examination. During a DRE, practitioners should assess the prostate to see if it is significantly:

Jagged
Hard
Irregular, as opposed to smooth.

 

Find out more:

Access GatewayC’s course ‘Prostate Cancer – Responding to a PSA Screening Request’ and collect up to 2 hours of CPD here.

Access this BMJ learning module here

Keep up to date: Twitter | Facebook | LinkedIn

Latest from the Blog

NEW COURSE LIVE: Breast Cancer Recurrence

NEW COURSE LIVE: Breast Cancer Recurrence

Thursday 25th March 2021 We are delighted to announce that the new Breast Cancer Recurrence course is available on GatewayC. There are an estimated 35,000 people living with secondary breast cancer in the UK. Breast cancers most commonly recur in the first 2-3 years...

read more

Related Posts

GatewayC Live

GatewayC Live

Have you signed up to our free GatewayC Live webinars? GatewayC Live is a programme of free live broadcast webinars developed for all healthcare professionals across England, but targeted at primary care. Our webinars are developed by and feature leading specialists,...

read more
4 Tips to Manage Barrett’s Oesophagus

4 Tips to Manage Barrett’s Oesophagus

Thursday 4th March 2021 Barrett's oesophagus is associated with an increased risk of oesophageal cancer. When supporting a patient with Barrett’s oesophagus, are you clear on how to manage the condition? 4 tips to manage Barrett’s oesophagus in primary care include:...

read more